What Is Point of Care Testing? A Chattanooga Quality Inspector on When Fast Results Fool You

Point-of-care testing (POCT) is a diagnostic test done at or near the patient—and it's right for maybe 50-60% of the use cases I review. For the other 40-50%, a clinical laboratory with a mass spectrometer is still the safer answer. If you need a result in minutes and the decision is reversible, get the POCT device. If the result has to survive a second look, a courtroom, or a medication dose, send it to the lab.

Quick disclaimer before I get into the details: I'm a quality/compliance manager for medical equipment in Chattanooga, and I don't cover police records. If you landed here after searching "recent arrests chattanooga tn," you're in the wrong place. But I'll use that search to make a point: an arrest list is not a conviction record, and a point-of-care result is not the same as a confirmatory lab result. Both are fast, both are useful, and both can fool you without context.

I've been in this role for 4 years, and I review roughly 250 distinct products a year. I rejected about 12% of first deliverables in 2024 because specs didn't match the actual clinical workflow. One of those was a POCT glucose meter where the package insert didn't match the validation data the clinic had been given. Nothing wrong with the device; everything wrong with the paperwork. That's the kind of gap that makes "fast and easy" fail in real life.

What Is Point of Care Testing?

If you've been asking "what is point of care testing," the shortest answer is: it's any test performed at or near the patient instead of in the central clinical laboratory. The classic examples are glucose meters, rapid strep tests, urine dipsticks, INR monitors, and some cardiac troponin cartridges. The sales pitch is real—turnaround time drops from hours to minutes.

The oversimplification is the next step: "faster means we don't need the lab." It's tempting to think that. But POCT moves the laboratory task to the person holding the device. That person is already doing four other things. A CLIA-waived test still requires operator training, daily QC, temperature logs, and a clear rule for what happens when the result doesn't match the patient.

I work with clinics near Miller Park Chattanooga, and I've watched a well-meaning staff member skip the external QC run because "it was a busy Tuesday." That one choice can turn a $2 test into a $20,000 liability when the result is wrong at 3 p.m. and someone acts on it. To be fair, this isn't because nurses are careless. It's because POCT asks them to be lab scientists without giving them the time.

Central Lab and Mass Spectrometry: Why "Slow" Is a Feature

Here's the thing I keep seeing: people think the clinical laboratory is slow because the machines are old. Actually, the lab is slow because it's accountable. A specimen has a chain of custody, extraction, internal standards, calibration curves, and an analyst who knows when a peak looks wrong. None of that can be compressed into a 90-second cartridge.

That's where the mass spectrometer comes in. If the question is "what is point of care testing vs mass spectrometry?" I'd put it this way: POCT is a screening question; mass spec is the confirmation answer. An LC-MS/MS can quantify immunosuppressants, antidepressants, antipsychotics, opioids, newborn metabolic markers, steroids, vitamin D—hundreds of compounds in one run. There isn't a point-of-care device that does that walk-up without a lab-trained operator, and I don't see one replacing it in the next decade. I might be wrong on the timeline, but I'd rather be wrong with a confirmatory test in my hand.

According to the CDC (cdc.gov, CLIA resources, accessed January 2025), CLIA-waived tests are simple tests with a low risk of erroneous results. That doesn't mean no risk; it means lower risk when run exactly as instructed. The FDA CLIA waiver database (fda.gov, accessed January 2025) is the authoritative list for what qualifies—not the vendor's brochure.

When POCT Is the Right Call

I don't want this to sound like I'm anti-POCT. It's often the best tool. If I were running a small clinic, I'd still want these in the building:

• Glucose meters for diabetes follow-up—patients notice trends without waiting for a lab callback.
• Rapid strep/flu tests in a family practice—same-day prescribing decisions.
• INR monitors in an anticoagulation clinic—dose adjustments happen before the patient leaves.
• A high-sensitivity troponin cartridge in an emergency department—not to rule in a heart attack, but to help rule one out quickly.

I went back and forth on that last one for a long time. In 2023, I helped a rural clinic decide between a POCT panel and a central analyzer. The POCT was faster; the central analyzer had better reimbursement, lower per-test cost, and less staff burden. We chose the central analyzer because the clinic had two nurses and no one to run daily QC. But I still think POCT is useful for after-hours or low-volume locations. The right answer depends on who will run it, not just what it measures.

Three Things a Point of Care Result Won't Tell You

This is where I sound like the boring quality person, and I'm okay with that:

• Whether the operator followed the exact sequence. One skipped step changes the result more than a $1,000 instrument upgrade.
• Whether the sample was good enough. Hemolyzed, diluted, or contaminated samples still produce numbers. POCT devices don't always know the difference.
• Whether a positive screen needs a second look. A rapid screen is not a confirmatory mass spec result.

How to Decide Without Regretting It Later

After reviewing equipment for four years, this is the rough filter I use. Take it with a grain of salt, because every facility is different.

1. How fast is medically necessary? If treatment starts while the patient is in front of you, POCT earns its place. If you can wait 45 minutes without changing the outcome, central lab is probably fine.
2. What's the cost of being wrong? False positives and negatives matter more than turnaround time. Confirmation should happen in a clinical laboratory.
3. Who will run it after the vendor leaves? If the answer is "the front desk person in between phone calls," budget for extra training and audit.
4. Will it talk to your EHR? A POCT result that gets written on a sticky note might as well not exist.

The Boundary I Keep Coming Back To

The vendor who says "we can replace your mass spectrometer with a box in the supply closet" is either lying or selling a dream. In 2024, I reviewed four POCT cartridges that claimed "lab-comparable" results. One had a package insert that said, literally, "not for use as the sole basis for diagnosis." The sales rep hadn't read it. I don't think he was being malicious—I think the marketing team had decided what the product was before the clinical team finished validating it.

Here's my personal rule, and it's not popular in every sales meeting: if someone promises a product has no limits, that's the first limit. A good specialist says "this isn't our strength—here's who does it better." That kind of honesty has earned my trust more times than a "one-stop shop" pitch ever has. The same applies to POCT: know what it's for, know what it's not for, and don't let a fast answer seduce you into skipping the confirmatory step.

So, if you're in Chattanooga and someone from your lab asks for another POCT device, ask the four questions above. If they want to replace their mass spectrometer with a box in a cart, ask for it in writing. And if you were here for the local arrests list—well, you can probably find it. Just remember that an arrest is not a conviction, and a rapid result is not the same as a diagnosis. Context matters in both cases.

Regulatory information is for general guidance only. Verify current CLIA waived status and requirements at the FDA CLIA waiver database (fda.gov) and your state health department.